{"result": "(\"entity\"<|>PACIENTE<|>PERSON<|>Paciente refers to an individual receiving medical treatment, particularly in the context of parenteral nutrition.)\n##\n(\"entity\"<|>TÉCNICA<|>EVENT<|>Técnica refers to the specialized methods and procedures used in administering parenteral nutrition.)\n##\n(\"entity\"<|>PERSONAL ESPECIALIZADO<|>PERSON<|>Personal especializado refers to the trained healthcare professionals responsible for administering parenteral nutrition and managing patient care.)\n##\n(\"entity\"<|>COMPLICACIONES MECÁNICAS<|>EVENT<|>Complicaciones mecánicas are potential adverse effects associated with the administration of parenteral nutrition, including issues like thrombophlebitis.)\n##\n(\"entity\"<|>COMPLICACIONES SÉPTICAS<|>EVENT<|>Complicaciones sépticas are infections that can occur as a result of parenteral nutrition administration.)\n##\n(\"entity\"<|>VITAMINAS Y MINERALES<|>EVENT<|>Vitaminas y minerales are essential nutrients that should be included in parenteral nutrition to ensure complete dietary support.)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN PARENTERAL<|>Paciente is the individual receiving parenteral nutrition treatment due to inability to consume food normally<|>9)\n##\n(\"relationship\"<|>PERSONAL ESPECIALIZADO<|>NUTRICIÓN PARENTERAL<|>Personal especializado administers and manages the parenteral nutrition for patients<|>8)\n##\n(\"relationship\"<|>TÉCNICA<|>NUTRICIÓN PARENTERAL<|>Técnica refers to the specialized methods used in the administration of parenteral nutrition<|>7)\n##\n(\"relationship\"<|>COMPLICACIONES MECÁNICAS<|>NUTRICIÓN PARENTERAL<|>Complicaciones mecánicas are risks associated with the administration of parenteral nutrition<|>6)\n##\n(\"relationship\"<|>COMPLICACIONES SÉPTICAS<|>NUTRICIÓN PARENTERAL<|>Complicaciones sépticas are risks associated with the administration of parenteral nutrition<|>6)\n##\n(\"relationship\"<|>VITAMINAS Y MINERALES<|>NUTRICIÓN PARENTERAL<|>Vitaminas y minerales are essential components that should be included in parenteral nutrition<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: cuando el soporte enteral no alcanza el 60% de los requerimientos del paciente.\n\n**NP vía central (NPC):** Es aquella NP que se administra por vía central debido a su elevada osmolaridad (mayor de 900 mOsm/L) y su pH entre 5,3 - 6,5. Su composición en general incluye glucosa, lípidos y aminoácidos. Suele cubrir las necesidades calórico-proteicas del paciente. Para su administración se necesita bombas de infusión, técnica y personal especializado. Se relaciona con un mayor riesgo de complicaciones mecánicas y sépticas. El periodo de administración suele ser mayor de 7 días.\n\n**NP vía periférica (NPP):** Se administran por vía periférica, su osmolaridad no debe superar los 800-900 mOsm/L, y su pH debe estar entre 6-7,4. Su menor osmolaridad limita los aportes proteicos y calóricos.\n\nSe recomienda una razón HC/lípidos de 60:40 y un límite de aporte lipídico de 1,3 g/Kg de peso/día y que no suponga más del 30% de las calorías totales.\nSu duración no debería ser superior a 7-10 días. No está indicada en los cuidados\n---\npaliativos como sistema de hidratación. Se recomienda que incluya el aporte diario de vitaminas y minerales.\n\nVentajas:\n- Rápida disponibilidad de acceso. Permite iniciar de manera inmediata el soporte nutricional.\n- Fácil manejo. No requiere personal especialmente cualificado para su colocación, ni requiere comprobación radiológica de su ubicación.\n- Menos complicaciones de tipo mecánico e infeccioso asociadas a su uso.\n- Menor coste.\n\nDesventajas:\n- Suele presentar como complicación frecuente la tromboflebitis.\n- No cubren los requerimientos completos de los pacientes.\n- La velocidad máxima de goteo se limita a 40 gotas/min. Se recomienda bomba de infusión.\n- Duración del tratamiento, máximo 7 días.\n\nNutrición Parenteral Hipocalórica (NPH). Se aportan menos calorías que las necesarias, generalmente 20 kcal/Kg/día. Se pretende alcanzar beneficios mediante la modulación de la respuesta metabólica y la corrección de la glucemia. Está indicada en el postoperatorio inmediato o en tratamientos de corta duración. Se administra por vía periférica.\n\nNP Domiciliaria (NPD): La administración de la nutrición parenteral se realiza en el domicilio del paciente. Se necesita un entorno familiar y social adecuado para poder realizar un correcto control de la NP.\n\nNP Continua: La administración de la NP se realiza en infusión normal de 24 horas. Se utiliza normalmente en el caso de NP hospitalaria y en enfermos domiciliarios con problemas de sobrecarga de volumen.\n\nNP Cíclica: La duración de la infusión es menor de 24 horas, generalmente de 12-16 horas (durante el día o por la noche). Se suele utilizar en pacientes domiciliarios. No se recomienda la administración en menos de 12-14 horas, para prevenir problemas de tolerancia y complicaciones metabólicas. No todos los enfermos la toleran ya que pueden presentar problemas con la glucemia, la lipemia y el volumen administrado.\n---\n## 2. INDICACIONES DE LA NP\n\nLa NP se aconseja cuando existe imposibilidad de utilizar el tubo digestivo o se encuentra contraindicado el soporte nutricional por vía enteral u oral, o los aportes son insuficientes.\n\n### Indicaciones de la NPC\n\nNormalmente, cuando el tiempo estimado de ayuno es mayor de 7 días, se trata de pacientes con alto estrés metabólico, intolerancia a sobrecarga hídrica, o desnutrición grave.\n\n| Indicaciones NPC |\n|-------------------|\n| **Absolutas:** |\n| • Vómitos persistentes e incontrolables |\n| • Hemorragias digestivas |\n| • Íleo paralítico |\n| • Obstrucción intestinal |\n| • Perforación intestinal |\n| • Isquemia intestinal |\n| **Relativas** |\n| • Fístulas yeyunales altas |\n| • Enfermedad inflamatoria en fase aguda |\n| • Síndrome de intestino corto grave (en el postoperatorio inmediato y crónicamente si se presenta fallo intestinal completo) |\n| • Maldigestión o malabsorción intestinal grave |\n| • Pancreatitis aguda grave |\n| • Enteritis aguda grave por radiación o por infección |\n\n| Indicaciones NPP |\n|-------------------|\n| • Íleo no quirúrgico |\n| • Pre-cirugía mayor, con malnutrición o tumores (gástricos o de colon) |\n| • Post-cirugía si existe una previsión de ayuno de entre 7-14 días y un grado de estrés leve- moderado |\n| • Previsión de ayuno de entre 7 -\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutrición Parenteral is a medical treatment that provides nutrition to patients who cannot eat or absorb food through their digestive system, often administered intravenously.)\n##\n(\"entity\"<|>NP VÍA CENTRAL<|>EVENT<|>NP vía central is a method of administering nutrition parenterally through a central vein, used for patients requiring high osmolarity solutions.)\n##\n(\"entity\"<|>NP VÍA PERIFÉRICA<|>EVENT<|>NP vía periférica is a method of administering nutrition parenterally through a peripheral vein, suitable for patients with lower osmolarity needs.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL HIPOCALÓRICA<|>EVENT<|>Nutrición Parenteral Hipocalórica is a type of parenteral nutrition that provides fewer calories than required, typically used in short-term treatments.)\n##\n(\"entity\"<|>NP DOMICILIARIA<|>EVENT<|>NP Domiciliaria refers to the administration of parenteral nutrition at the patient's home, requiring a suitable family and social environment for proper management.)\n##\n(\"entity\"<|>NP CONTINUA<|>EVENT<|>NP Continua is a method of administering parenteral nutrition continuously over 24 hours, often used in hospital settings.)\n##\n(\"entity\"<|>NP CÍCLICA<|>EVENT<|>NP Cíclica is a method of administering parenteral nutrition for less than 24 hours, typically used for home patients.)\n##\n(\"relationship\"<|>NP VÍA CENTRAL<|>NUTRICIÓN PARENTERAL<|>NP vía central is a specific method of administering parenteral nutrition for patients needing high osmolarity solutions<|>8)\n##\n(\"relationship\"<|>NP VÍA PERIFÉRICA<|>NUTRICIÓN PARENTERAL<|>NP vía periférica is a specific method of administering parenteral nutrition for patients with lower osmolarity needs<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL HIPOCALÓRICA<|>NUTRICIÓN PARENTERAL<|>Nutrición Parenteral Hipocalórica is a type of parenteral nutrition that provides fewer calories than required, thus it is a subset of parenteral nutrition<|>7)\n##\n(\"relationship\"<|>NP DOMICILIARIA<|>NUTRICIÓN PARENTERAL<|>NP Domiciliaria is a method of administering parenteral nutrition at home, which is a form of parenteral nutrition<|>7)\n##\n(\"relationship\"<|>NP CONTINUA<|>NUTRICIÓN PARENTERAL<|>NP Continua is a method of administering parenteral nutrition continuously, which is a form of parenteral nutrition<|>7)\n##\n(\"relationship\"<|>NP CÍCLICA<|>NUTRICIÓN PARENTERAL<|>NP Cíclica is a method of administering parenteral nutrition for less than 24 hours, which is a form of parenteral nutrition<|>7)\n<|COMPLETE|>"}]}